Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention
J. Yarmolinsky, M.A. Lee, E. Lau, F. Moratalla-Navarro, E.E. Vincent, R. Li-Gao, P.C.N. Rensen, K.W. van Dijk, K.K. Tsilidis, A. Sangphukieo, E. Ebrahimi, J. Hampe, L. Le Marchand, F.J.B. van Duijnhoven, K. Visvanathan, M.O. Woods, M. Guevara, S. Sieri, G. Masala, K. Papier, S. Virani, T. Dudding, A. Dehghan, D. Wang, V. Moreno, M.J. Gunter, I. Tzoulaki
doi: https://doi.org/10.1101/2024.11.20.24317649
J. Yarmolinsky
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
M.A. Lee
2Nutrition and Metabolism Branch (NME), International Agency for Research on Cancer, Lyon, France
E. Lau
3Institute for Human Development and Potential, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore
F. Moratalla-Navarro
4Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, 08908 Barcelona, Spain
5ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, Spain
6Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain
7Department of Clinical Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Faculty of Medicine, University of Barcelona, 08007 Barcelona, Spain
E.E. Vincent
8MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
9Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK,
10Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
R. Li-Gao
11Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
P.C.N. Rensen
12Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands
13Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
K.W. van Dijk
12Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands
13Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
14Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands
K.K. Tsilidis
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
15Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
A. Sangphukieo
16Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
E. Ebrahimi
16Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
J. Hampe
17Department of Medicine I, University Hospital Dresden, Technische Universität Dresden (TU Dresden), Dresden, Germany
L. Le Marchand
18University of Hawaii Cancer Center, Honolulu, Hawaii, USA
F.J.B. van Duijnhoven
19Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
K. Visvanathan
20Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
M.O. Woods
21Memorial University of Newfoundland, Discipline of Genetics, St. John’s, Canada
M. Guevara
22Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain
23Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
24Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
S. Sieri
25Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
G. Masala
26Clinical Epidemiology Unit, Institute for cancer research, prevention and clinical network (ISPRO), Florence, Italy
K. Papier
27Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
S. Virani
16Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
T. Dudding
28Bristol Dental School, University of Bristol, Bristol, UK
A. Dehghan
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
29Dementia Research Institute, Imperial College London, London United Kingdom
D. Wang
3Institute for Human Development and Potential, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore
30National Heart and Lung Institute, Imperial College London, London, UK
V. Moreno
4Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, 08908 Barcelona, Spain
5ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, Spain
6Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain
7Department of Clinical Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Faculty of Medicine, University of Barcelona, 08007 Barcelona, Spain
M.J. Gunter
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
2Nutrition and Metabolism Branch (NME), International Agency for Research on Cancer, Lyon, France
I. Tzoulaki
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
29Dementia Research Institute, Imperial College London, London United Kingdom
31Systems Biology, Biomedical Research Foundation Academy of Athens, Athens, Greece
Article usage
Posted November 23, 2024.
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention
J. Yarmolinsky, M.A. Lee, E. Lau, F. Moratalla-Navarro, E.E. Vincent, R. Li-Gao, P.C.N. Rensen, K.W. van Dijk, K.K. Tsilidis, A. Sangphukieo, E. Ebrahimi, J. Hampe, L. Le Marchand, F.J.B. van Duijnhoven, K. Visvanathan, M.O. Woods, M. Guevara, S. Sieri, G. Masala, K. Papier, S. Virani, T. Dudding, A. Dehghan, D. Wang, V. Moreno, M.J. Gunter, I. Tzoulaki
medRxiv 2024.11.20.24317649; doi: https://doi.org/10.1101/2024.11.20.24317649
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention
J. Yarmolinsky, M.A. Lee, E. Lau, F. Moratalla-Navarro, E.E. Vincent, R. Li-Gao, P.C.N. Rensen, K.W. van Dijk, K.K. Tsilidis, A. Sangphukieo, E. Ebrahimi, J. Hampe, L. Le Marchand, F.J.B. van Duijnhoven, K. Visvanathan, M.O. Woods, M. Guevara, S. Sieri, G. Masala, K. Papier, S. Virani, T. Dudding, A. Dehghan, D. Wang, V. Moreno, M.J. Gunter, I. Tzoulaki
medRxiv 2024.11.20.24317649; doi: https://doi.org/10.1101/2024.11.20.24317649
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2940)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)